Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BioNexus Gene Lab Corp. stock logo
BGLC
BioNexus Gene Lab
$5.93
-7.8%
$3.36
$2.01
$15.60
$10.67M5.08498,264 shs347,863 shs
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
$1.52
-1.9%
$1.72
$1.21
$2.55
$11.40M75.28142,648 shs40,178 shs
Mitesco, Inc. stock logo
MITI
Mitesco
$0.38
+12.5%
$0.34
$0.00
$1.00
$4.24M1.6712,250 shs972 shs
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
$0.80
$0.83
$0.65
$0.99
$10.24M-0.0315,239 shsN/A
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BioNexus Gene Lab Corp. stock logo
BGLC
BioNexus Gene Lab
0.00%+127.76%+103.52%+116.06%+36.00%
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
0.00%-1.61%-12.24%-6.55%-15.29%
Mitesco, Inc. stock logo
MITI
Mitesco
0.00%+20.64%-3.15%-39.65%+17.05%
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
0.00%0.00%-11.11%+11.11%-9.09%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
BioNexus Gene Lab Corp. stock logo
BGLC
BioNexus Gene Lab
0.4092 of 5 stars
0.05.00.00.01.10.00.0
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
2.7301 of 5 stars
3.53.00.00.00.63.30.6
Mitesco, Inc. stock logo
MITI
Mitesco
N/AN/AN/AN/AN/AN/AN/AN/A
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BioNexus Gene Lab Corp. stock logo
BGLC
BioNexus Gene Lab
0.00
N/AN/AN/A
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
3.00
Buy$18.001,084.21% Upside
Mitesco, Inc. stock logo
MITI
Mitesco
0.00
N/AN/AN/A
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BioNexus Gene Lab Corp. stock logo
BGLC
BioNexus Gene Lab
$9.51M1.12N/AN/A$4.63 per share1.28
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
$400K28.50N/AN/A$1.23 per share1.24
Mitesco, Inc. stock logo
MITI
Mitesco
$40K105.99N/AN/A($2.70) per share-0.14
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
$6.07M1.69$0.07 per share11.15$0.91 per share0.88
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BioNexus Gene Lab Corp. stock logo
BGLC
BioNexus Gene Lab
-$1.60MN/A0.00N/A-22.85%-24.18%-20.14%N/A
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
-$8.98M-$1.47N/AN/AN/A-3,093.61%-129.47%-86.02%8/12/2025 (Estimated)
Mitesco, Inc. stock logo
MITI
Mitesco
-$2.51MN/A0.00N/A1,456.66%N/A-1,202.21%N/A
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
$880K$0.0711.43N/A15.18%8.47%7.97%8/5/2025 (Estimated)

Latest MITI, BRTX, BGLC, and PFHO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2025Q1 2025
BioNexus Gene Lab Corp. stock logo
BGLC
BioNexus Gene Lab
N/A-$0.03N/A-$0.03N/AN/A
5/15/2025Q1 2025
Mitesco, Inc. stock logo
MITI
Mitesco
N/A-$0.08N/A-$0.08N/A$0.02 million
5/14/2025Q1 2025
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
-$0.32-$0.56-$0.24-$0.64$0.38 million$0.03 million
5/2/2025Q1 2025
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
N/A$0.02N/A$0.02N/A$1.82 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BioNexus Gene Lab Corp. stock logo
BGLC
BioNexus Gene Lab
N/AN/AN/AN/AN/A
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
N/AN/AN/AN/AN/A
Mitesco, Inc. stock logo
MITI
Mitesco
N/AN/AN/AN/AN/A
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BioNexus Gene Lab Corp. stock logo
BGLC
BioNexus Gene Lab
N/A
4.19
3.44
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
N/A
2.24
2.24
Mitesco, Inc. stock logo
MITI
Mitesco
N/AN/AN/A
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
N/A
18.55
18.55

Institutional Ownership

CompanyInstitutional Ownership
BioNexus Gene Lab Corp. stock logo
BGLC
BioNexus Gene Lab
18.85%
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
69.38%
Mitesco, Inc. stock logo
MITI
Mitesco
0.01%
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
BioNexus Gene Lab Corp. stock logo
BGLC
BioNexus Gene Lab
301.80 million1.78 millionNot Optionable
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
77.50 million5.59 millionNot Optionable
Mitesco, Inc. stock logo
MITI
Mitesco
3011.16 million10.61 millionNot Optionable
Pacific Health Care Organization Inc. stock logo
PFHO
Pacific Health Care Organization
3012.80 million4.92 millionNot Optionable

Recent News About These Companies

PAHO insists on the importance of universal access to care
PAHO warns of increase in yellow fever cases
PAHO warns of NCDs spreading in the region
Waipahu High School offers hands-on health care training
Metro Pacific Health, mWell ink referral partnership
DLR Group Appoints Healthcare Design Project Leader for Pacific Northwest

New MarketBeat Followers Over Time

Media Sentiment Over Time

BioNexus Gene Lab stock logo

BioNexus Gene Lab NASDAQ:BGLC

$5.93 -0.50 (-7.78%)
Closing price 04:00 PM Eastern
Extended Trading
$5.78 -0.15 (-2.46%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers. Its products are used to produce handrails, bench tops, automotive and aero parts, and paneling for hospital, laboratory, industrial clean rooms, and covers for various instruments used in manufacturing. The company also involves in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers to detect potential risk of diseases. It markets its products through its website, warehouse, marketing personnel, and suppliers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

Biorestorative Therapies stock logo

Biorestorative Therapies NASDAQ:BRTX

$1.52 -0.03 (-1.94%)
Closing price 04:00 PM Eastern
Extended Trading
$1.54 +0.01 (+0.99%)
As of 06:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtxDisc) includes a lead cell therapy candidate, BRTX-100, a product candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, which has completed Phase 1 clinical trials for use in the non-surgical treatment of painful lumbosacral disc disorders. The company is also developing Metabolic Program (ThermoStem), a cell-based therapy candidate that is in preclinical stage to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. In addition, it provides investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; a research agreement with Pfizer, Inc.; and a research collaboration agreement with the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. The company was incorporated in 1997 and is based in Melville, New York.

Mitesco stock logo

Mitesco OTCMKTS:MITI

$0.38 +0.04 (+12.46%)
As of 02:51 PM Eastern

Mitesco, Inc. does not have significant operations. Previously, it was engaged in healthcare technology and services business. Mitesco, Inc. is based in Vero Beach, Florida.

Pacific Health Care Organization stock logo

Pacific Health Care Organization OTCMKTS:PFHO

$0.80 0.00 (0.00%)
As of 07/3/2025

Pacific Health Care Organization, Inc., together with its subsidiaries, operates as a specialty workers' compensation cost containment company in the United States. It is involved in managing and administering health care organizations (HCOs) and medical provider networks (MPNs). The company also provides claims-related services, including utilization review, medical case management, medical bill review, employee advocate services, workers' compensation carve-outs, expert witness testimony, and Medicare set-aside services. It serves insurers, third party administrators, self-administered employers, municipalities, and other industries. The company was formerly known as Clear Air, Inc. and changed its name to Pacific Health Care Organization, Inc. in January 2001. Pacific Health Care Organization, Inc. was incorporated in 1970 and is based in Irvine, California.